Status: Approved
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Schizophrenia Phase 2 ClinicalTrials
Cocaine-Related Disorders Phase 2 ClinicalTrials
Schizophrenia Phase 2 ClinicalTrials
Syndrome; Tourette Syndrome Phase 4 ClinicalTrials
Cognition Disorders; Cognitive Dysfunction; Psychotic Disorders; Schizophrenia Phase 3 ClinicalTrials
Schizophrenia Phase 2 ClinicalTrials
Schizophrenia Phase 2 ClinicalTrials
Psychotic Disorders; Schizophrenia Phase 2 ClinicalTrials
Mood Disorders; Psychotic Disorders; Schizophrenia Phase 1/Phase 2 ClinicalTrials
Schizophrenia Phase 2 ClinicalTrials
Psychotic Disorders; Schizophrenia Phase 2 ClinicalTrials
Psychotic Disorders; Schizophrenia Phase 3 ClinicalTrials
CONTENTS